A. Robert, J. J. Adams, and . Fournier, Sobolev spaces, Pure and Applied Mathematics, vol.140, 2003.

O. Angulo and J. C. López-marcos, Numerical schemes for size-structured population equations, Deterministic models with applications in population dynamics and other fields of biology, pp.169-188, 1997.
DOI : 10.1016/S0025-5564(98)10081-0

D. [. Araujo and . Mcelwain, A history of the study of solid tumour growth: the contribution of mathematical modelling, Bulletin of Mathematical Biology, vol.66, issue.5, pp.1039-1091, 2004.
DOI : 10.1016/j.bulm.2003.11.002

[. Ambrosi and L. Preziosi, ON THE CLOSURE OF MASS BALANCE MODELS FOR TUMOR GROWTH, Mathematical Models and Methods in Applied Sciences, vol.12, issue.05, pp.737-754, 2002.
DOI : 10.1080/10273669908833027

. Gentet, Metronomic etoposide/cyclophosphamide/celecoxib regimen to children and adolescents with refractory cancer : a preliminary monocentric study, Clin. Therapeutics, vol.30, issue.7, pp.1336-1340, 2008.

N. S. Benzekry, A. André, J. Benabdallah, C. Ciccolini, F. Faivre et al., Modelling the impact of anticancer agents on metastatic spreading, 2012.

]. C. Bar70 and . Bardos, Problèmes aux limites pour les équations aux dérivées partielles du premier ordre à coefficients réels ; théorèmes d'approximation ; application à l'équation de transport, Ann. Sci. École Norm. Sup, vol.3, issue.4, pp.185-233, 1970.

A. [. Benzekry and . Benabdallah, An optimal control problem for anti-cancer therapies in a model for metastatic evolution. in preparation, 2011.

]. D. Bbb-+-11, A. Barbolosi, S. Benabdallah, J. Benzekry, C. Ciccolini et al., A mathematical model for growing metastases on oncologist's service, 2011.

J. Brikci, B. Clairambault, B. Ribba, and . Perthame, An age-and-cyclin-structured cell population model for healthy and tumoral tissues, Journal of Mathematical Biology, vol.16, issue.6, pp.91-110, 2008.
DOI : 10.1128/MCB.16.6.2554
URL : https://hal.archives-ouvertes.fr/inria-00081301

A. [. Barbolosi, F. Benabdallah, F. Hubert, and . Verga, Mathematical and numerical analysis for a model of growing metastatic tumors, Mathematical Biosciences, vol.218, issue.1, pp.1-14, 2009.
DOI : 10.1016/j.mbs.2008.11.008
URL : https://hal.archives-ouvertes.fr/hal-00262335

]. T. Bbk-+-00, C. E. Browder, B. M. Butterfield, B. Kraling, B. Shi et al., Antiangiogenic scheduling of chemotherapy improves efficacy against experimental drug-resistant cancer, Cancer Res, vol.60, pp.1878-1886, 2000.

T. Bresch, E. Colin, B. Grenier, O. Ribba, and . Saut, Computational Modeling of Solid Tumor Growth: The Avascular Stage, SIAM Journal on Scientific Computing, vol.32, issue.4, pp.2321-2344, 2010.
DOI : 10.1137/070708895
URL : https://hal.archives-ouvertes.fr/inria-00148610

S. Baruchel, M. Diezi, D. Hargrave, D. Stempak, J. Gammon et al., Safety and pharmacokinetics of temozolomide using a dose-escalation, metronomic schedule in recurrent paediatric brain tumours, European Journal of Cancer, vol.42, issue.14, pp.2335-2342, 2006.
DOI : 10.1016/j.ejca.2006.03.023

]. S. Ben11a and . Benzekry, Mathematical analysis of a two-dimensional population model of metastatic growth including angiogenesis Mathematical and numerical analysis of a model for anti-angiogenic therapy in metastatic cancers, J. Evol. Equ, vol.11, issue.1, pp.187-213, 2011.

]. S. Ben11c and . Benzekry, Passing to the limit 2D-1D in a model for metastatic growth. to appear in, J. Biol. Dyn, 2011.

[. Boyer and P. Fabrie, Éléments d'analyse pour l'étude de quelques modèles d'écoulements de fluides visqueux incompressibles, ) [Mathematics & Applications, 2006.
DOI : 10.1007/3-540-29819-3

G. [. Barbolosi, J. Freyer, A. Ciccolini, and . Iliadis, Optimisation de la posologie et des modalités d'administration des agents cytotoxiques à l'aide d'un modèle mathématique, Bulletin du Cancer, vol.90, issue.2, pp.167-175, 2003.

A. Bertuzzi, A. Fasano, A. Gandolfi, and C. Sinisgalli, Tumour Cords and Their Response to Anticancer Agents, Selected topics in cancer modeling, pp.183-206, 2008.
DOI : 10.1007/978-0-8176-4713-1_7

A. [. Bertuzzi and . Gandolfi, Cell Kinetics in a Tumour Cord, Journal of Theoretical Biology, vol.204, issue.4, pp.587-599, 2000.
DOI : 10.1006/jtbi.2000.1079

A. [. Barbolosi and . Iliadis, Optimizing drug regimens in cancer chemotherapy: a simulation study using a PK???PD model, Computers in Biology and Medicine, vol.31, issue.3, pp.157-172, 2001.
DOI : 10.1016/S0010-4825(00)00032-9

F. Billy, Modélisation mathématique multi-échelle de l'angiogenèse tumorale Analyse de la réponse tumorale aux traitements anti-angiogéniques, 2009.

F. [. Banks and . Kappel, Transformation semigroups andL 1-approximation for size structured population models, Semigroup Forum, vol.25, issue.1, pp.141-155, 1988.
DOI : 10.1007/978-1-4612-5561-1

F. Boyer, [. Beals, and V. Protopopescu, Trace theorems and spatial continuity properties for the solutions of the transport equation Abstract time-dependent transport equations, Differential Integral Equations J. Math. Anal. Appl, vol.18, issue.1212, pp.891-934370, 1987.

. Brs-+-09-]-f, B. Billy, O. Ribba, H. Saut, T. Morre-trouilhet et al., A pharmacologically based multiscale mathematical model of angiogenesis and its use in investigating the efficacy of a new cancer treatment strategy, J. Theor. Biol, vol.260, issue.4, pp.545-62, 2009.

H. M. Byrne, I. M. Van-leeuwen, M. R. Owen, T. Alarcón, and P. K. Maini, Multiscale Modelling of Solid Tumour Growth, Selected topics in cancer modeling, pp.449-473, 2008.
DOI : 10.1007/978-0-8176-4713-1_17

]. R. Bvv-+-96, N. Bruno, J. C. Vivier, S. L. Vergniol, G. De-phillips et al., A population pharmacokinetic model for docetaxel (Taxotere) : model building and validation, J Pharmacokinet Biopharm, vol.24, pp.153-172, 1996.

. Cbb-+-11-]-p, C. Correale, A. Botta, M. Basile, A. Pagliuchi et al., Phase II trial of bevacizumab and dose/dense chemotherapy with cisplatin and metronomic daily oral etoposide in advanced non-small-cell-lung cancer patients, Cancer Biol Ther, vol.12, 2011.

]. M. Ces84 and . Cessenat, Théorèmes de trace L p pour des espaces de fonctions de la neutronique, C. R. Acad. Sci. Paris Sér. I Math, vol.299, issue.16, pp.831-834, 1984.

]. M. Ces85 and . Cessenat, Théorèmes de trace pour des espaces de fonctions de la neutronique, C. R. Acad. Sci. Paris Sér. I Math, vol.300, issue.3, pp.89-92, 1985.

M. Casanova, A. Ferrari, G. Bisogno, J. H. Merks, G. L. De-salvo et al., Vinorelbine and low-dose cyclophosphamide in the treatment of pediatric sarcomas, Cancer, vol.11, issue.7, pp.1664-1671, 2004.
DOI : 10.1002/cncr.20544

M. Chefrour, J. L. Fischel, P. Formento, S. Giacometti, R. M. Ferri-dessens et al., Erlotinib in Combination with Capecitabine (5'dFUR) in Resistant Pancreatic Cancer Cell Lines, Journal of Chemotherapy, vol.26, issue.5, pp.129-133, 2010.
DOI : 10.1200/jco.2008.26.15_suppl.4516

L. [. Comen, J. Norton, and . Massague, Clinical implications of cancer self-seeding, Nature Reviews Clinical Oncology, vol.18
DOI : 10.1016/j.coi.2006.01.011

. Macdonald, Feasibility of metronomic maintenance chemotherapy following highdose chemotherapy for malignant central nervous system tumors, Pediatr Blood Cancer, vol.50, pp.970-975, 2008.

. A. Dbrr-+-00-]-t, I. H. Drixler, E. D. Borel-rinkes, T. J. Ritchie, M. F. Van-vroonhoven et al., Continuous administration of angiostatin inhibits accelerated growth of colorectal liver metastases after partial hepatectomy, Cancer Res, vol.60, pp.1761-1765, 2000.

[. Demengel and G. Demengel, Espaces fonctionnels Savoirs Actuels (Les Ulis) [Current Scholarship (Les Ulis, EDP Sciences, Les Ulis, 2007.

[. Demailly, Numerical analysis and differential equations, Analyse numérique et équations différentielles.) Nouvelle éd. Grenoble : Presses Univ. de Grenoble. 309 p, 1996.

[. Vore, R. Fehrenbacher, and R. Herbst, A randomized phase ii trial comparing rhumab vegf (recombinant humanized monoclonal antibody to vascular endothelial cell growth factor) plus carboplatin/paclitaxel (cp) to cp alone in patients with stage iiib/iv nsclc Tumour eradication by antiangiogenic therapy : analysis and, Proc Am Soc Clin Oncol Math. Biosci, vol.19, issue.1912, pp.159-184, 1999.

]. A. Onofrio and A. Gandolfi, Chemotherapy of vascularised tumours: Role of vessel density and the effect of vascular ???pruning???, Journal of Theoretical Biology, vol.264, issue.2, pp.253-265, 2010.
DOI : 10.1016/j.jtbi.2010.01.023
URL : https://hal.archives-ouvertes.fr/hal-00585792

]. A. Onofrio and A. Gandolfi, Resistance to antitumor chemotherapy due to bounded-noise-induced transitions, Physical Review E, vol.60, issue.6, p.61901, 2010.
DOI : 10.1103/RevModPhys.70.223

T. [. Devys, P. Goudon, and . Laffitte, A model describing the growth and the size distribution of multiple metastatic tumors, Discrete and Continuous Dynamical Systems - Series B, vol.12, issue.4, pp.731-767, 2009.
DOI : 10.3934/dcdsb.2009.12.731
URL : https://hal.archives-ouvertes.fr/inria-00351489

]. A. Onofrio, A. Gandolfi, and A. Rocca, The dynamics of tumour-vasculature interaction suggests low-dose, time-dense anti-angiogenic schedulings, Cell Proliferation, vol.356, issue.18S, Suppl, pp.317-329, 2009.
DOI : 10.3934/mbe.2005.2.511

R. J. Diperna and P. Lions, Ordinary differential equations, transport theory and Sobolev spaces, Inventiones Mathematicae, vol.307, issue.3, pp.511-547, 1989.
DOI : 10.1007/BFb0061716

A. Onofrio, U. Ledzewicz, H. Maurer, and H. Schättler, On optimal delivery of combination therapy for tumors, Mathematical Biosciences, vol.222, issue.1, pp.13-26, 2009.
DOI : 10.1016/j.mbs.2009.08.004

]. F. Dos53 and . Dost, Der blütspiegel-kinetic der konzentrationsablaüfe in der frieslaufflüssigkeit, Thieme, p.244, 1953.

]. M. Dou07 and . Doumic, Analysis of a population model structured by the cells molecular content, Math. Model. Nat. Phenom, vol.2, issue.3, pp.121-152, 2007.

]. J. Dro01a and . Droniou, Intégration et espaces de sobolev à valeurs vectorielles, 2001.

]. J. Dro01b and . Droniou, Quelques résultats sur les espaces de sobolev, 2001.

A. H. Enderling, M. A. Anderson, A. Chaplain, L. Beheshti, P. Hlatky et al., Paradoxical Dependencies of Tumor Dormancy and Progression on Basic Cell Kinetics, Cancer Research, vol.69, issue.22, pp.8814-8821, 2009.
DOI : 10.1158/0008-5472.CAN-09-2115

K. [. Ergun, L. M. Camphausen, and . Wein, Optimal Scheduling of Radiotherapy and Angiogenic Inhibitors, Bulletin of Mathematical Biology, vol.65, issue.3, pp.407-424, 2003.
DOI : 10.1016/S0092-8240(03)00006-5
URL : http://faculty-gsb.stanford.edu/wein/personal/Optimal Scheduling of Radiotherapy.pdf

. M. Elcm-+-09-]-j, C. R. Ebos, W. Lee, G. A. Crus-munoz, J. G. Bjarnason et al., Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis, Cancer Cell, vol.15, pp.232-239, 2009.

D. [. Echenim, M. Monniaux, F. Sorine, [. Clément, R. Engel et al., Multi-scale modeling of the follicle selection process in the ovary, Mathematical Biosciences, vol.198, issue.1, pp.57-79, 2000.
DOI : 10.1016/j.mbs.2005.05.003
URL : https://hal.archives-ouvertes.fr/inria-00343961

. P. Esc-+-02-]-j, J. G. Eder, J. W. Supko, T. A. Clark, R. Puchalski et al., Phase I clinical trial of recombinant human endostatin administered as a short intravenous infusion repeated daily, J. Clin. Oncol, vol.20, pp.3772-3784, 2002.

. B. Fdm-+-10-]-a, S. Francesconi, M. Dupre, D. Matos, B. G. Martin et al., Carboplatin and etoposide combined with bevacizumab for the treatment of recurrent glioblastoma multiforme, J Clin Neurosci, vol.17, pp.970-974, 2010.

M. [. Fasano, A. Gabrielli, and . Gandolfi, Investigating the steady state of multicellular spheroids by revisiting the two-fluid model, Mathematical Biosciences and Engineering, vol.8, issue.2, pp.239-252, 2011.
DOI : 10.3934/mbe.2011.8.239

J. Folkman, Anti-Angiogenesis, Annals of Surgery, vol.175, issue.3, pp.409-416, 1972.
DOI : 10.1097/00000658-197203000-00014

A. Friedman, A hierarchy of cancer models and their mathematical challenges, Discrete and Continuous Dynamical Systems - Series B, vol.4, issue.1
DOI : 10.3934/dcdsb.2004.4.147

]. G. Gcl-+-07, S. J. Guzman, A. Y. Cotler, A. J. Lin, R. Maniotis et al., A pilot study of vasculogenic mimicry immunohistochemical expression in hepatocellular carcinoma, Arch. Pathol. Lab. Med, vol.131, pp.1776-1781, 2007.

E. [. Gatenby and . Gawlinski, A reaction-diffusion model of cancer invasion, Cancer Res, vol.56, pp.5745-5753, 1996.

G. Giaccone, R. S. Herbst, C. Manegold, G. Scagliotti, R. Rosell et al., Gefitinib in Combination With Gemcitabine and Cisplatin in Advanced Non???Small-Cell Lung Cancer: A Phase III Trial???INTACT 1, Journal of Clinical Oncology, vol.22, issue.5, pp.777-784, 2004.
DOI : 10.1200/JCO.2004.08.001

R. [. Gasparini, M. Longo, B. A. Fanelli, and . Teicher, Combination of Antiangiogenic Therapy With Other Anticancer Therapies: Results, Challenges, and Open Questions, Journal of Clinical Oncology, vol.23, issue.6, pp.1295-1311, 2005.
DOI : 10.1200/JCO.2005.10.022

P. [. Gatenby and . Maini, Mathematical oncology: Cancer summed up, Nature, vol.421, issue.6921, p.321, 2003.
DOI : 10.1038/421321a

J. [. Gupta and . Massagué, Cancer Metastasis: Building a Framework, Cell, vol.127, issue.4, pp.679-695, 2006.
DOI : 10.1016/j.cell.2006.11.001
URL : https://doi.org/10.1016/j.cell.2006.11.001

]. B. Gom25 and . Gompertz, On the nature of the function expressive of the law of human mortality and on a new mode of determining the nature of life contingencier. Letter to Francis Baily, pp.513-585

P. [. Girault and . Raviart, Finite element approximation of the Navier-Stokes equations, Lecture Notes in Mathematics, vol.749, 1979.
DOI : 10.1007/BFb0063447

]. H. Gre72 and . Greenspan, Models for the growth of a solid tumor by diffusion, Studies in Applied Mathematics, vol.52, pp.317-340, 1972.

G. [. Gyllenberg and . Webb, Quiescence as an explanation of gompertzian tumor growth, Growth, Development and Aging, vol.53, pp.25-33, 1989.

A. H. Hansma, H. J. Broxterman, I. Van-der-horst, Y. Yuana, E. Boven et al., Recombinant human endostatin administered as a 28-day continuous intravenous infusion, followed by daily subcutaneous injections: a phase I and pharmacokinetic study in patients with advanced cancer, Annals of Oncology, vol.16, issue.10
DOI : 10.1093/annonc/mdi318

P. Hahnfeldt, J. Folkman, and L. Hlatky, Minimizing Long-Term Tumor Burden: The Logic for Metronomic Chemotherapeutic Dosing and its Antiangiogenic Basis, Journal of Theoretical Biology, vol.220, issue.4, pp.545-554, 2003.
DOI : 10.1006/jtbi.2003.3162

H. Hurwitz, L. Fehrenbacher, W. Novotny, T. Cartwright, J. Hainsworth et al., Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal Cancer, New England Journal of Medicine, vol.350, issue.23, pp.2335-2342, 2004.
DOI : 10.1056/NEJMoa032691

P. Hinow, P. Gerlee, L. J. Mccawley, V. Quaranta, M. Ciobanu et al., A spatial model of tumorhost interaction : application of chemotherapy, Math. Biosci. Eng, vol.6, issue.3, pp.521-546, 2009.

. S. Hgs-+-05-]-r, G. Herbst, J. H. Giaccone, R. B. Schiller, V. Natale et al., Tribute : a phase iii trial of erlotinib hydrochloride (osi-774) combined with carboplatin and paclitaxel chemotherapy in advanced non-small-cell lung cancer, J. Clin. Oncol, vol.23, issue.25, pp.5892-5899, 2005.

M. Hatakeyama, S. Kimura, T. Naka, T. Kawasaki, N. Yumoto et al., A computational model on the modulation of mitogen-activated protein kinase (MAPK) and Akt pathways in heregulin-induced ErbB signalling, Biochemical Journal, vol.373, issue.2, pp.451-463, 2003.
DOI : 10.1042/bj20021824

D. [. Hahnfeldt, J. Panigraphy, L. Folkman, and . Hlatky, Tumor development under angiogenic signaling : a dynamical theory of tumor growth, treatment, response and postvascular dormancy, Cancer Research, vol.59, pp.4770-4775, 1999.

R. S. Herbst, D. Prager, R. Hermann, L. Fehrenbacher, B. E. Johnson et al., Gefitinib in Combination With Paclitaxel and Carboplatin in Advanced Non???Small-Cell Lung Cancer: A Phase III Trial???INTACT 2, Journal of Clinical Oncology, vol.22, issue.5, pp.785-794, 2004.
DOI : 10.1200/JCO.2004.07.215

D. Hanahan and R. A. Weinberg, The Hallmarks of Cancer, Cell, vol.100, issue.1, pp.57-70, 2000.
DOI : 10.1016/S0092-8674(00)81683-9

]. M. Ian95 and . Ianelli, Mathematical theory of age-structured population dynamics, Applied Mathematical Monographs, C.N.R.I. Giardini Editori e Stampatori, 1995.

D. [. Iliadis and . Barbolosi, Dosage regimen calculations with optimal control theory, International Journal of Bio-Medical Computing, vol.36, issue.1-2, pp.87-93, 1994.
DOI : 10.1016/0020-7101(94)90098-1

D. [. Iliadis and . Barbolosi, Optimizing Drug Regimens in Cancer Chemotherapy by an Efficacy???Toxicity Mathematical Model, Computers and Biomedical Research, vol.33, issue.3, pp.211-226, 2000.
DOI : 10.1006/cbmr.2000.1540
URL : http://www.wseas.us/e-library/conferences/corfu2004/papers/488-176.pdf

K. Iwata, K. Kawasaki, and N. Shigesada, A Dynamical Model for the Growth and Size Distribution of Multiple Metastatic Tumors, Journal of Theoretical Biology, vol.203, issue.2, pp.177-186, 2000.
DOI : 10.1006/jtbi.2000.1075

]. R. Jai01 and . Jain, Normalizing tumor vasculature with anti-angiogenic therapy : A new paradigm for combination therapy, Nature Medicine, vol.7, pp.987-989, 2001.

D. [. Jain, J. W. Duda, J. S. Clark, and . Loeffler, Lessons from phase III clinical trials on anti-VEGF therapy for cancer, Nature Clinical Practice Oncology, vol.25, issue.1, pp.24-40, 2005.
DOI : 10.1016/j.urolonc.2004.01.011

H. K. Jordan, W. Wolf, T. Voigt, L. P. Kegel, T. Mueller et al., Bevacizumab in combination with sequential high-dose chemotherapy in solid cancer, a feasibility study, Bone Marrow Transplantation, vol.71, issue.12, pp.1704-1709, 2010.
DOI : 10.1158/1078-0432.CCR-08-2170

. Kbp-+-01-]-o, C. M. Kisker, D. Becker, M. Prox, R. D. Fannon et al., Continuous administration of endostatin by intraperitoneally implanted osmotic pump improves the efficacy and potency of therapy in a mouse xenograft tumor model, Cancer Res, vol.61, pp.7669-7674, 2001.

]. B. Kho00 and . Kholodenko, Negative feedback and ultrasensitivity can bring about oscillations in the mitogen-activated protein kinase cascades, Eur. J. Biochem, vol.267, pp.1583-1588, 2000.

B. [. Kerbel and . Kamen, The anti-angiogenic basis of metronomic chemotherapy, Nature Reviews Cancer, vol.22, issue.6, pp.423-436, 2004.
DOI : 10.1007/978-1-4419-8871-3_19

M. [. Kunz-schughart, R. Kreutz, and . Knuechel, Multicellular spheroids: a three-dimensional in vitro culture system to study tumour biology, International Journal of Experimental Pathology, vol.62, issue.42, pp.1-23, 1998.
DOI : 10.1038/bjc.1990.266

M. W. Kieran, C. D. Turner, J. B. Rubin, S. N. Chi, M. A. Zimmerman et al., A Feasibility Trial of Antiangiogenic (Metronomic) Chemotherapy in Pediatric Patients With Recurrent or Progressive Cancer, Journal of Pediatric Hematology/Oncology, vol.27, issue.11, pp.27573-581, 2005.
DOI : 10.1097/01.mph.0000183863.10792.d4

]. A. Lai64 and . Laird, Dynamics of tumor growth, Br. J. Cancer, vol.13, pp.490-502, 1964.

A. Y. Lin, Z. Ai, S. C. Lee, P. Bajcsy, J. Pe-'er et al., Comparing Vasculogenic Mimicry With Endothelial Cell-lined Vessels: Techniques for 3D Reconstruction and Quantitative Analysis of Tissue Components from Archival Paraffin Blocks, Applied Immunohistochemistry & Molecular Morphology, vol.15, issue.1, pp.113-119, 2007.
DOI : 10.1097/01.pai.0000210414.15375.47

. F. Lbe-+-08-]-j, R. Lu, S. Bruno, W. Eppler, B. Novotny et al., Clinical pharmacokinetics of bevacizumab in patients with solid tumors, Cancer Chemother . Pharmacol, vol.62, pp.779-786, 2008.

V. Wise and . Cristini, Nonlinear modelling of cancer : bridging the gap between cells and tumours, Nonlinearity, vol.23, issue.1, pp.1-91, 2010.

J. [. Liotta, G. M. Kleinerman, and . Saidel, Quantitative relationships of intravascular tumor cells, tumor vessels, and pulmonary metastases following tumor implantation, Cancer Res, vol.34, pp.997-1004, 1974.

[. Ledzewicz, Y. Liu, and H. Schättler, The effect of pharmacokinetics on optimal protocols for a mathematical model of tumor anti-angiogenic therapy, 2009 American Control Conference, pp.1060-1065, 2009.
DOI : 10.1109/ACC.2009.5159849

U. Ledzewicz, J. Marriott, H. Maurer, and H. Schättler, Realizable protocols for optimal administration of drugs in mathematical models for anti-angiogenic treatment, Mathematical Medicine and Biology, vol.27, issue.2, pp.157-179, 2010.
DOI : 10.1093/imammb/dqp012

[. Ledzewicz, J. Munden, and H. Schättler, Scheduling of angiogenic inhibitors for Gompertzian and logistic tumor growth models, Discrete and Continuous Dynamical Systems - Series B, vol.12, issue.2, pp.415-438, 2009.
DOI : 10.3934/dcdsb.2009.12.415

[. Ledzewicz and H. Schättler, The influence of pk/pd on the structure of optimal controls in cancer chemotherapy models, Math. Biosci. Eng, vol.2, issue.3, pp.561-578, 2005.

[. Ledzewicz and H. Schättler, Drug resistance in cancer chemotherapy as an optimal control problem, Discrete Contin. Dyn. Syst. Ser. B, vol.6, issue.1, pp.129-150, 2006.

[. Ledzewicz and H. Schättler, AntiAngiogenic Therapy in Cancer Treatment as an Optimal Control Problem, SIAM Journal on Control and Optimization, vol.46, issue.3, pp.1052-1079, 2007.
DOI : 10.1137/060665294

G. [. Liotta, J. Saidel, and . Kleinerman, Stochastic Model of Metastases Formation, Biometrics, vol.32, issue.3, pp.535-550, 1976.
DOI : 10.2307/2529743

. D. Mch-+-05-]-k, L. I. Miller, F. A. Chap, M. A. Holmes, P. K. Cobleigh et al., Randomized phase III trial of capecitabine compared with bevacizumab plus capecitabine in patients with previously treated metastatic breast cancer, J. Clin. Oncol, vol.23, pp.792-799, 2005.

]. A. Mck26 and . Mckendrick, Applications of mathematics to medical problems, Proc. Edin, pp.98-130, 1926.

O. [. Metz and . Diekmann, The dynamics of physiologically structured populations, Lecture Notes in Biomathematics, vol.68, 1983.
DOI : 10.1007/978-3-662-13159-6

C. Meille, A. Iliadis, D. Barbolosi, N. Frances, and G. Freyer, An interface model for dosage adjustment connects hematotoxicity to pharmacokinetics, Journal of Pharmacokinetics and Pharmacodynamics, vol.63, issue.6, pp.619-633, 2008.
DOI : 10.1007/BF02462379

M. [. Michaelis and . Menten, Die kinetik der invertinwirking, Biochem. Z, vol.49, pp.333-369, 1913.

S. [. Michel, B. Mischler, and . Perthame, General relative entropy inequality: an illustration on growth models, Journal de Math??matiques Pures et Appliqu??es, vol.84, issue.9, pp.1235-1260111, 2004.
DOI : 10.1016/j.matpur.2005.04.001
URL : https://doi.org/10.1016/j.matpur.2005.04.001

M. R. Owen, T. Alarcón, P. K. Maini, and H. M. Byrne, Angiogenesis and vascular remodelling in normal and cancerous tissues, Journal of Mathematical Biology, vol.235, issue.2, pp.4-5689, 2009.
DOI : 10.1007/s00285-003-0262-2

A. [. Shaughnessy and . Brufsky, RiBBON 1 and RiBBON 2: Phase III Trials of Bevacizumab with Standard Chemotherapy for Metastatic Breast Cancer, Clinical Breast Cancer, vol.8, issue.4, pp.370-373, 2008.
DOI : 10.3816/CBC.2008.n.045

. S. Ohs-+-94-]-m, L. O-'reilly, Y. Holmgren, C. Shing, R. A. Chen et al., Angiostatin : a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma, Cell, vol.79, pp.315-328, 1994.

]. L. Per01 and . Perko, Differential equations and dynamical systems, of Texts in Applied Mathematics, 2001.

]. B. Per07 and . Perthame, Transport equations in biology, Frontiers in Mathematics. Birkhäuser Verlag, 2007.

. C. Pkg-+-03-]-j, M. N. Panetta, A. Kirstein, G. Gajjar, M. Nair et al., Population pharmacokinetics of temozolomide and metabolites in infants and children with primary central nervous system tumors, Cancer Chemother. Pharmacol, vol.52, pp.435-441, 2003.

M. Paez-ribes, E. Allen, J. Hudock, T. Takeda, H. Okuyama et al., Antiangiogenic Therapy Elicits Malignant Progression of Tumors to Increased Local Invasion and Distant Metastasis, Cancer Cell, vol.15, issue.3, pp.220-231, 2009.
DOI : 10.1016/j.ccr.2009.01.027

]. R. Pre93 and . Prehn, Two competing influences that may explain concomitant tumor resistance, Cancer Res, vol.53, pp.3266-3269, 1993.

S. [. Perthame and . Tumuluri, Nonlinear Renewal Equations, Selected topics in cancer modeling, pp.65-96, 2008.
DOI : 10.1007/978-0-8176-4713-1_4

L. [. Qu, J. Guo, Y. Ma, and . Lv, Antiangiogenesis therapy might have the unintended effect of promoting tumor metastasis by increasing an alternative circulatory system, Medical Hypotheses, vol.74, issue.2, pp.360-361, 2010.
DOI : 10.1016/j.mehy.2009.08.020

T. [. Ribba, S. Colin, and . Schnell, A multiscale mathematical model of cancer, and its use in analyzing irradiation therapies. theoretical biology and medical modelling, Theoretical Biology and Medical Modelling, vol.3, issue.7, 2010.
URL : https://hal.archives-ouvertes.fr/hal-00756367

. J. Rdg-+-11-]-n, V. Robert, J. Dieras, A. M. Glaspy, I. Brufsky et al., RIBBON-1 : Randomized, Double-Blind, Placebo-Controlled, Phase III Trial of Chemotherapy With or Without Bevacizumab for First-Line Treatment of Human Epidermal Growth Factor Receptor 2-Negative, Locally Recurrent or Metastatic Breast Cancer, J Clin Oncol, 2011.

. A. Rdp-+-11-]-d, A. Reardon, K. Desjardins, S. Peters, J. Gururangan et al., Phase II study of metronomic chemotherapy with bevacizumab for recurrent glioblastoma after progression on bevacizumab therapy, J. Neurooncol, vol.103, pp.371-379, 2011.

]. A. Rey10 and . Reynolds, Potential relevance of bell-shaped and u-shaped dose-responses for the therapeutic targeting of angiogenesis in cancer, Dose-Response, vol.8, pp.253-284, 2010.

G. J. Riely, N. A. Rizvi, M. G. Kris, D. T. Milton, D. B. Solit et al., Randomized Phase II Study of Pulse Erlotinib Before or After Carboplatin and Paclitaxel in Current or Former Smokers With Advanced Non???Small-Cell Lung Cancer, Journal of Clinical Oncology, vol.27, issue.2, pp.264-270, 2009.
DOI : 10.1200/JCO.2008.17.4656

O. B. Ribba, T. Saut, D. Colin, E. Bresch, J. P. Grenier et al., A multiscale mathematical model of avascular tumor growth to investigate the therapeutic benefit of anti-invasive agents, Journal of Theoretical Biology, vol.243, issue.4, pp.532-541, 2006.
DOI : 10.1016/j.jtbi.2006.07.013
URL : https://hal.archives-ouvertes.fr/inria-00332464

]. D. Sgh-+-06, J. Stempak, J. Gammon, A. Halton, G. Moghrabi et al., A pilot pharmacokinetic and antiangiogenic biomarker study of celecoxib and low-dose metronomic vinblastine or cyclophosphamide in pediatric recurrent solid tumors, J. Pediatr. Hematol. Oncol, vol.28, pp.720-728, 2006.

]. P. Ske86 and . Skehan, On the normality of growth dynamics of neoplasms in vivo : a data base analysis, Growth, vol.50, pp.496-515, 1986.

L. [. Saidel, J. Liotta, and . Kleinerman, System dynamics of a metastatic process from an implanted tumor, Journal of Theoretical Biology, vol.56, issue.2, pp.417-434, 1976.
DOI : 10.1016/S0022-5193(76)80083-5

M. Simeoni, P. Magni, C. Cammia, G. De-nicolao, V. Croci et al., Predictive Pharmacokinetic-Pharmacodynamic Modeling of Tumor Growth Kinetics in Xenograft Models after Administration of Anticancer Agents, Cancer Research, vol.64, issue.3, pp.1094-1101, 2004.
DOI : 10.1158/0008-5472.CAN-03-2524

J. [. Spratt, J. A. Meyer, and . Spratt, Rates of growth of human neoplasms: Part II, Journal of Surgical Oncology, vol.164, issue.1, pp.143-150, 1996.
DOI : 10.1016/B978-0-12-287460-4.50007-2

. Snv-+-10-]-g, S. Scagliotti, P. J. Novello, M. Von, J. R. Reck et al., Phase iii study of carboplatin and paclitaxel alone or with sorafenib in advanced non-small-cell lung cancer, J. Clin. Oncol, issue.11, pp.281835-1842, 2010.

D. R. Spigel, P. M. Townley, D. M. Waterhouse, L. Fang, I. Adiguzel et al., Randomized Phase II Study of Bevacizumab in Combination With Chemotherapy in Previously Untreated Extensive-Stage Small-Cell Lung Cancer: Results From the SALUTE Trial, Journal of Clinical Oncology, vol.29, issue.16, pp.2215-2222, 2011.
DOI : 10.1200/JCO.2010.29.3423

D. [. Serrin and . Varberg, A General Chain Rule for Derivatives and the Change of Variables Formula for the Lebesgue Integral, The American Mathematical Monthly, vol.76, issue.5, pp.514-520, 1969.
DOI : 10.2307/2316959

]. J. Svm-+-06, D. Sterba, P. Valik, T. Mudry, Z. Kepak et al., Combined biodifferentiating and antiangiogenic oral metronomic therapy is feasible and effective in relapsed solid tumors in children : single-center pilot study, Onkologie, vol.29, pp.308-313, 2006.

]. G. Swa88 and . Swan, General applications of optimal control theory in cancer chemotherapy, IMA J. Math. Appl. Med. Biol, vol.5, issue.4, pp.303-316, 1988.

]. G. Swa90 and . Swan, Applications of optimal control theory in biomedicine, Math. Biosc, vol.101, pp.237-284, 1990.

]. L. Tar07 and . Tartar, An introduction to Sobolev spaces and interpolation spaces, of Lecture Notes of the Unione Matematica Italiana, 2007.

S. [. Tucker and . Zimmerman, A Nonlinear Model of Population Dynamics Containing an Arbitrary Number of Continuous Structure Variables, SIAM Journal on Applied Mathematics, vol.48, issue.3, pp.549-591, 1988.
DOI : 10.1137/0148032

]. P. Ver45 and . Verhulst, Recherches mathématiques sur la loi d'accroissement de la population Nouveaux mémoires de l'Académie royale de Bruxelles, Ver10] F. Verga. Modélisation mathématique de processus métastatiques, pp.1-42, 1845.

]. J. Wag81, . F. Wagnerweb85-]-g, and . Webb, History of pharmacokinetics Theory of nonlinear age-dependent population dynamics, of Monographs and Textbooks in Pure and Applied Mathematics, pp.537-562, 1981.

R. Weinberg, The Biology of Cancer, 2007.

J. [. Widmark and . Tandberg, Über die bedingungen für die akkumulation indifferenter narkoliken theoretische bereckerunger, Biochem Z, vol.3, pp.358-369, 1924.